Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)‐experience from an Italian oncology network

New approach to implement cancer patient care: The valutazione percorso rete oncologica campana... INTRODUCTIONCancer disease is still the second cause of death in developed countries. According to the estimates provided by Italian Association of Medical Oncology (Associazione Italiana di Oncologia Medica, AIOM) and Italian Association of Cancer Registries (Associazione Italiana Registro Tumori, AIRTUM) working groups in 2021, cancer mortality rates are decreasing for both sexes, with a percentage reduction of 10% in men and 8% in women compared to 2015 in Italy. This decreased mortality was related to greater attention and progress made by Italian National Health Service (NHS) in the implementation and organisation of cancer screening programmes and more active involvement of the general population (Camilloni et al., 2013). While Southern regions of Italy seem to have an advantage compared to Northern regions in terms of incidence rate, the same is not true for the survival; an explanation could be the low aptitude for screening programmes (Petrelli et al., 2018). As an example, in 2019, only 40% of women living in Southern Italy and Islands had joined breast cancer screening programme compared to 61% in Northern Italy and 53% in Central Italy according to the National Centre for Screening Monitoring Report (‘Osservatorio Nazionale di Screening',  2019). Low compliance to screening programmes could determine http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)‐experience from an Italian oncology network

Download PDF
14 pages

Loading next page...
 
/lp/wiley/new-approach-to-implement-cancer-patient-care-the-valutazione-percorso-e5T2IjYby3
Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13736
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONCancer disease is still the second cause of death in developed countries. According to the estimates provided by Italian Association of Medical Oncology (Associazione Italiana di Oncologia Medica, AIOM) and Italian Association of Cancer Registries (Associazione Italiana Registro Tumori, AIRTUM) working groups in 2021, cancer mortality rates are decreasing for both sexes, with a percentage reduction of 10% in men and 8% in women compared to 2015 in Italy. This decreased mortality was related to greater attention and progress made by Italian National Health Service (NHS) in the implementation and organisation of cancer screening programmes and more active involvement of the general population (Camilloni et al., 2013). While Southern regions of Italy seem to have an advantage compared to Northern regions in terms of incidence rate, the same is not true for the survival; an explanation could be the low aptitude for screening programmes (Petrelli et al., 2018). As an example, in 2019, only 40% of women living in Southern Italy and Islands had joined breast cancer screening programme compared to 61% in Northern Italy and 53% in Central Italy according to the National Centre for Screening Monitoring Report (‘Osservatorio Nazionale di Screening',  2019). Low compliance to screening programmes could determine

Journal

European Journal of Cancer Care – Wiley

Published: Nov 1, 2022

Keywords: Campania Oncology Network; cancer care; cancer delay; continuity of care; multidisciplinary oncologic groups

References

  • Methods to increase participation in organised screening programs: A systematic review
    Camilloni, L.; Ferroni, E.; Cendales, B. J.; Pezzarossi, A.; Furnari, G.; Borgia, P.; Guasticchi, G.; Rossi, P. G.
  • Association between mode of breast cancer detection and diagnosis delay
    Crispo, A.; Montella, M.; Barba, M.; Schittulli, F.; Marco, M. R.; Grimaldi, M.; Quaranta, M.; Serravezza, G.; Savastano, C.; Botti, G.; Vecchia, C.; D'Aiuto, G.
  • A new strategy for a high tumour burden region: The Campania oncological network
    De Placido, S.; Bracale, U.; Pacelli, R.; Sodo, M.; Merola, G.; Silvestri, V.; Corcione, F.
  • Determinazione della numerosità campionaria
    Di Napoli, A.; Franco, F.
  • Assessing the impact of clinical coordination interventions on the continuity of care for patients with chronic conditions: Participatory action research in five Latin American countries
    Espinel‐Flores, V.; Vargas, I.; Eguiguren, P.; Mogollón‐Pérez, A. S.; Ferreira de Medeiros Mendes, M.; López‐Vázquez, J.; Bertolotto, F.; Vázquez, M. L.
  • A retrospective analysis of delays in the diagnosis of lung cancer and associated costs
    Gildea, T. R.; DaCosta Byfield, S.; Hogarth, D. K.; Wilson, D. S.; Quinn, C. C.
  • Cancer care coordination: A systematic review and meta‐analysis of over 30 years of empirical studies
    Gorin, S. S.; Haggstrom, D.; Han, P. K. J.; Fairfield, K. M.; Krebs, P.; Clauser, S. B.
  • Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
    Guarneri, V.; Bassan, F.; Zagonel, V.; Milella, M.; Zaninelli, M.; Cattelan, A. M.; Vianello, A.; Gori, S.; Aprile, G.; Azzarello, G.; Chiari, R.; Favaretto, A.; Oliani, C.; Scola, A.; Pastorelli, D.; Mandarà, M.; Zustovich, F.; Bernardi, D.; Chiarion‐Sileni, V.
  • Mortality due to cancer treatment delay: Systematic review and meta‐analysis
    Hanna, T. P.; King, W. D.; Thibodeau, S.; Jalink, M.; Paulin, G. A.; Harvey‐Jones, E.; O'Sullivan, D. E.; Booth, C. M.; Sullivan, R.; Aggarwal, A.
  • Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma
    Hester, C. A.; Karbhari, N.; Rich, N. E.; Augustine, M.; Mansour, J. C.; Polanco, P. M.; Porembka, M. R.; Wang, S. C.; Zeh, H. J.; Singal, A. G.; Yopp, A. C.
  • Timeliness of cancer care in a regional Victorian health service: A comparison of high‐volume (lung) and low‐volume (oesophagogastric) tumour streams
    Kabwe, M.; Robinson, A.; Shethia, Y.; Parker, C.; Blum, R.; Solo, I.; Leach, M.
  • Timeliness of cancer care from diagnosis to treatment: A comparison between patients with breast, colon, rectal or lung cancer
    Li, X.; Scarfe, A.; King, K.; Fenton, D.; Butts, C.; Winget, M.
  • The application of the diagnostic therapeutic care pathway for the geriatric patient with anemia at the hospital of Cosenza, Italy: A management tool or a quality project?
    Loizzo, M.; Cuccurullo, O.; Gallo, F.
  • Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
    Neal, R. D.; Tharmanathan, P.; France, B.; Din, N. U.; Cotton, S.; Fallon‐Ferguson, J.; Hamilton, W.; Hendry, A.; Hendry, M.; Lewis, R.; Macleod, U.; Mitchell, E. D.; Pickett, M.; Rai, T.; Shaw, K.; Stuart, N.; Tørring, M. L.; Wilkinson, C.; Williams, B.; Emery, J.
  • Expected medium‐ and long‐term impact of the COVID‐19 outbreak in oncology
    Onesti, C. E.; Tagliamento, M.; Curigliano, G.; Harbeck, N.; Bartsch, R.; Wildiers, H.; Tjan‐Heijnen, V.; Martin, M.; Rottey, S.; Generali, D.; Campone, M.; Cristofanilli, M.; Pusztai, L.; Peeters, M.; Berchem, G.; Cortes, J.; Ruhstaller, T.; Ciruelos, E.; Rugo, H. S.; Jerusalem, G.
  • The role of telehealth during the COVID‐19 pandemic across the interdisciplinary cancer team: Implications for practice
    Paterson, C.; Bacon, R.; Dwyer, R.; Morrison, K. S.; Toohey, K.; O'Dea, A.; Slade, J.; Mortazavi, R.; Roberts, C.; Pranavan, G.; Cooney, C.; Nahon, I.; Hayes, S. C.
  • Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: Results from the National Health Interview Survey
    Petrelli, A.; Giorgi Rossi, P.; Francovich, L.; Giordani, B.; Napoli, A.; Zappa, M.; Mirisola, C.; Gargiulo, L.
  • The impact of the COVID‐19 pandemic on cancer care
    Richards, M.; Anderson, M.; Carter, P.; Ebert, B. L.; Mossialos, E.
  • Assessment of the oncological offer among Italian regions: A patient‐centered analysis
    Rova, A.; Tettamanti, A.; Pinto, L.; Urbinati, D.
  • Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: A modeling study
    Rutter, C. M.; Kim, J. J.; Meester, R. G. S.; Sprague, B. L.; Burger, E. A.; Zauber, A. G.; Ergun, M. A.; Campos, N. G.; Doubeni, C. A.; Trentham‐Dietz, A.; Sy, S.; Alagoz, O.; Stout, N.; Lansdorp‐Vogelaar, I.; Corley, D. A.; Tosteson, A. N. A.